European Archives - Page 133 of 996 - European Medical Journal

Irritable Bowel Syndrome and Dyspepsia Following Acute Gastroenteritis

Research explores the prevalence of post-infection irritable bowel syndrome and functional dyspepsia after acute gastroenteritis.

Metabolic and Physiological Changes May Predict Pancreatic Cancer Diagnosis

Changes in body composition and metabolic markers could enable the early detection of pancreatic ductal adenocarcinoma.

Effects of Persistent Smoking on Cancer Care Explored

A new study stresses the importance of a universal screening and opt-out referral strategy that may mitigate disparities in tobacco treatment access and use in cancer care.

Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers

A new study highlights significant disparities in next-generation sequencing testing among patients with metastatic prostate cancer and advanced urothelial carcinoma.

WHO launches avian flu vaccine initiative for LMICs

With avian influenza posing an ongoing public health threat, a new initiative has been launched to better prepare low- and middle-income countries.

 Designing an excellent customer experience journey

In today’s fast-paced pharma industry, it is vital for companies to provide an excellent customer experience for healthcare professionals.

Benefits of Swapping to One Vegetarian Meal in Patients with Cirrhosis

Substituting just one meat-based meal with a vegetarian or vegan alternative has been proven to reduce serum ammonia levels for up to 3 hours in patients with cirrhosis, according to a recent study

Innovative Immunotherapies Offer Hope for Patients with Liver Cancer

Prevalence of hepatocellular carcinoma is rising, particularly in Western countries, research shows that a new treatment modality has the potential to transform care for patients

Dupilumab Reduces Atopic March Risk in Paediatric Patients

Recent findings suggest that dupilumab, a monoclonal antibody treatment for atopic dermatitis, may significantly reduce the risk of atopic march in children.

Phase I Cancer Trials Show Equal Benefits for All Races

A recent study showed that racial and ethnic minority groups have historically been underrepresented in clinical trials.